We discovered that inhibiting PRDX1 by Celastrol or its analogs caused ROS elevation and then suppressed the proliferation of colorectal cancer cells, while NAC treatment reversed the apoptotic phenotypes. This evidence concerns the gene PRDX1 and colorectal cancer.